Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD7 is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. It is expressed on thymocytes, mature T lymphocytes, NK cells, and a subset of pre-B lymphocytes. CD7 plays a crucial role in T-cell interactions, early lymphoid development, and costimulatory signaling during T-cell activation. It serves as an immunohistochemical marker for T-lineage malignancies and aberrant expression patterns are associated with specific myeloid disorders and cutaneous T-cell lymphomas. CD7 is also being explored as a target for CAR-T cell therapy in aggressive leukemias.
Chimeric antigen receptor (CAR) therapies targeting CD7
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD7 antigen (CD7).